Research has implicated both peripheral immune and brain-derived interleukin-2 (IL-2) in neurologic disease processes that arise during CNS development (e.g., autism) to neurodegenerative alterations involving neuroinflammation (e.g., Alzheimer’s disease) [1]. The gene discussed is IL2; the disease is Alzheimer disease.